Malaria remains a leading cause of childhood morbidity and mortality in sub-Saharan Africa,
particularly among children under 5 years of age. To help address this challenge, the WHO …

Background The intermittent administration of seasonal malaria chemoprevention (SMC) is
recommended to prevent malaria among children aged 3–59 months in areas of the Sahel …

Background Implemented in 17 countries to date, seasonal malaria chemoprevention (SMC)
is a recommended strategy to prevent childhood malaria in areas with seasonal …

Background Seasonal malaria chemoprevention (SMC) is recommended in the Sahel
region of Africa for children under 5 years of age, for up to 4 months of the year. It may be …

Background Preterm birth is the leading cause of death in children younger than 5 years
worldwide. WHO recommends kangaroo mother care (KMC); however, its effects on …

Background Global efforts to scale-up malaria control interventions are gaining steam.
These include the use of Long-Lasting Insecticide Nets, Indoor Residual Spraying …

Background Malaria is still a major cause of morbidity and mortality among children aged< 5
y (U5s). This study assessed individual, household and community risk factors for malaria in …

Intermittent preventive treatment (IPT) with dihydroartemisinin-piperaquine (DP) is highly
protective against malaria in children, but is not standard in malaria-endemic countries …

Community-wide administration of antimalarial drugs in therapeutic doses is a potential tool
to prevent malaria infection and reduce the malaria parasite reservoir. To measure the …

Despite a significant reduction in the burden of malaria in children under five years-old, the
efficient implementation of seasonal malaria chemoprevention (SMC) at large scale remains …